Antibody Specificity Following a Recent Infection in Adolescence Is Correlated With the Pertussis Vaccine Received in Childhood.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsRaeven, René H M
van der Maas, Larissa
Pennings, Jeroen L A
Jørgensen, Charlotte Sværke
van Riet, Elly
Kersten, Gideon F A
MetadataShow full item record
TitleAntibody Specificity Following a Recent Infection in Adolescence Is Correlated With the Pertussis Vaccine Received in Childhood.
Published inFront Immunol 2019; 10:1364
- Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.
- Authors: Dalby T, Petersen JW, Harboe ZB, Krogfelt KA
- Issue date: 2010 Sep
- Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
- Authors: Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A, Stage III Working Group.
- Issue date: 2001 Nov
- Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children.
- Authors: von Linstow ML, Pontoppidan PL, von König CH, Cherry JD, Hogh B
- Issue date: 2010 Sep
- Whooping cough surveillance in France in pediatric private practice in 2006-2015.
- Authors: Guiso N, Levy C, Romain O, Guillot S, Werner A, Rondeau MC, Béchet S, Cohen R
- Issue date: 2017 Oct 27
- Acquisition of specific antibodies and their influence on cell-mediated immune response in neonatal cord blood after maternal pertussis vaccination during pregnancy.
- Authors: Lima L, Molina MDGF, Pereira BS, Nadaf MLA, Nadaf MIV, Takano OA, Carneiro-Sampaio M, Palmeira P
- Issue date: 2019 May 1
Showing items related by title, author, creator and subject.
Detection of opsonizing antibodies directed against a recently circulating Bordetella pertussis strain in paired plasma samples from symptomatic and recovered pertussis patients.Hovingh, Elise S; Kuipers, Betsy; Bonačić Marinović, Axel A; Jan Hamstra, Hendrik; Hijdra, Danielle; Mughini Gras, Lapo; van Twillert, Inonge; Jongerius, Ilse; van Els, Cecile A C M; Pinelli, Elena (2018-08-13)Correlates of protection (CoPs) against the highly contagious respiratory disease whooping cough, caused by Bordetella pertussis, remain elusive. Characterizing the antibody response to this pathogen is essential towards identifying potential CoPs. Here, we evaluate levels, avidity and functionality of B. pertussis-specific-antibodies from paired plasma samples derived from symptomatic and recovered pertussis patients, as well as controls. Natural infection is expected to induce protective immunity. IgG levels and avidity to nine B. pertussis antigens were determined using a novel multiplex panel. Furthermore, opsonophagocytosis of a B. pertussis clinical isolate by neutrophils was measured. Findings indicate that following infection, B. pertussis-specific antibody levels of (ex-) pertussis patients waned, while the avidity of antibodies directed against the majority of studied antigens increased. Opsonophagocytosis indices decreased upon recovery, but remained higher than controls. Random forest analysis of all the data revealed that 28% of the opsonophagocytosis index variances could be explained by filamentous hemagglutinin- followed by pertussis toxin-specific antibodies. We propose to further explore which other B. pertussis-specific antibodies can better predict opsonophagocytosis. Moreover, other B. pertussis-specific antibody functions as well as the possible integration of these functions in combination with other immune cell properties should be evaluated towards the identification of CoPs against pertussis.
Side-effects of pertussis toxin, pertussis vaccines and haemoinfluenza type B vaccinevan Amsterdam JGC; te Biesebeek JD; van de Kuil A; Vleeming W; van der Laan JW; Spruyt B; Wemer J; de Wildt DJ; LEO; LGM (Rijksinstituut voor Volksgezondheid en Milieu RIVM, 1997-04-30)Doel van de studie is de bijwerkingen van vaccins nader te bestuderen ter onderbouwing van voor te stellen richtlijnen. Bedoelde richtlijnen stellen eisen aan het verrichten van pre-klinische veiligheids-farmacologie van vaccins. Dit rapport beschrijft de cardiovasculaire en autonome effecten, die in-vivo worden waargenomen in jonge en volwassen ratten behandeld met hoge doseringen pertussis toxine, cellulair (DKTP-vaccin) en acellulair pertussis vaccin en Haemoinfluenza type b vaccin. Deze effecten refereren wellicht aan de collaps (flauwvallen) van de kinderen tijdens of vlak na de vaccinatie met kinkhoest vaccin. De belangrijkste effecten, die door pertussis toxine, DKTP and acellulair pertussis vaccin worden geinduceerd zijn hypotensie, tachycardie en remming van de adrenerge en cholinerge responsen. Volwassen ratten blijken gevoeliger voor deze stoffen te zijn dan jonge ratten en de respons hangt af van de toedieningsroute. Er worden geen effecten waargenomen in ratten, die behandeld zijn met DTP (deze mist de pertussis component) en Haemoinfluenza vaccin. Het wordt aanbevolen om de veiligheid van vaccins vast te stellen via bepaling van de cardiovasculaire en autonome bijwerkingen in volwassen ratten, die 3-4 keer met hoge dosis (20x de klinische dosering) en een middelhoge dosis zijn behandeld. Ten einde de klinische relevantie van de resultaten van het veiligheidsonderzoek afdoende vast te kunnen stellen, dient tot slot nog onderzocht te worden of herhaald i.m. toedienen van middelhoge dosis vaccins aan volwassen ratten dezelfde effecten induceert als waargenomen na i.v. toediening.<br>
Antibody responses to Bordetella pertussis and other childhood vaccines in infants born to mothers who received pertussis vaccine in pregnancy - a prospective, observational cohort study from the United Kingdom.Rice, T F; Diavatopoulos, D A; Smits, G P; van Gageldonk, P G M; Berbers, G A M; van der Klis, F R; Vamvakas, G; Donaldson, B; Bouqueau, M; Holder, B; et al. (2019-02-13)The maternal Tdap (tetanus, diphtheria and acellular pertussis) vaccination programme in the United Kingdom has successfully reduced cases of pertussis in young infants. In addition to prevention of pertussis cases, it is also important to investigate the persistence of maternal antibodies during infancy and the possible interference of maternal antibodies with infant responses to vaccines. We recruited mother-infant pairs from vaccinated and unvaccinated pregnancies and measured concentrations of immunoglobulin (Ig)G against pertussis toxin (PTx), filamentous haemagglutinin (FHA), pertactin (Prn), diphtheria toxin (DTx), tetanus toxoid (TTx) Haemophilus influenzae type b (Hib) and Streptococcus pneumoniae in mothers and infants at birth, and in infants at 7 weeks and at 5 months. Thirty-one mother-infant pairs were tested. Tdap-vaccinated women had significantly higher antibody against Tdap antigens, compared to unvaccinated women (DTx, P = 0·01; PTx, FHA, Prn and TTx, P < 0·001). All antibodies were actively transferred to the infants (transfer ratio > 1) with higher transfer of DTx (P = 0·04) and TTx (P = 0·02) antibody in Tdap-vaccinated pregnancies compared to unvaccinated pregnancies. Infants from Tdap-vaccinated pregnancies had significantly elevated antibodies to all antigens at birth (P < 0.001) and at 7 weeks (FHA, Prn, TTx, P < 0·001; DTx, P = 0.01; PTx, P = 0·004) compared to infants from unvaccinated pregnancies. Infants from Tdap-vaccinated and -unvaccinated pregnancies had comparable antibody concentrations following primary pertussis immunization (PTx, P = 0·77; FHA, P = 0·58; Prn, P = 0·60; DTx, P = 0·09; TTx, P = 0·88). These results support maternal immunization as a method of protecting vulnerable infants during their first weeks of life.